BlackRock’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,954,171
| Closed | -$49M | – | 6092 |
|
|
2022
Q1 | $49M | Sell |
11,954,171
-69,025
| -0.6% | -$250K | ﹤0.01% | 2600 |
|
|
2021
Q4 | $42.9M | Buy |
12,023,196
+147,703
| +1% | +$517K | ﹤0.01% | 2757 |
|
|
2021
Q3 | $43.2M | Buy |
11,875,493
+187,324
| +2% | +$757K | ﹤0.01% | 2762 |
|
|
2021
Q2 | $51M | Sell |
11,688,169
-387,411
| -3% | -$1.58M | ﹤0.01% | 2694 |
|
|
2021
Q1 | $49.6M | Buy |
12,075,580
+249,427
| +2% | +$1.08M | ﹤0.01% | 2616 |
|
|
2020
Q4 | $47.2M | Buy |
11,826,153
+336,315
| +3% | +$1.09M | ﹤0.01% | 2509 |
|
|
2020
Q3 | $31M | Sell |
11,489,838
-257,548
| -2% | -$713K | ﹤0.01% | 2598 |
|
|
2020
Q2 | $32.3M | Buy |
11,747,386
+404,213
| +4% | +$1.13M | ﹤0.01% | 2525 |
|
|
2020
Q1 | $26.8M | Sell |
11,343,173
-129,659
| -1% | -$441K | ﹤0.01% | 2448 |
|
|
2019
Q4 | $53.9M | Buy |
11,472,832
+256,030
| +2% | +$1.05M | ﹤0.01% | 2318 |
|
|
2019
Q3 | $37.5M | Buy |
11,216,802
+312,496
| +3% | +$1.03M | ﹤0.01% | 2460 |
|
|
2019
Q2 | $35.9M | Buy |
10,904,306
+993,787
| +10% | +$2.88M | ﹤0.01% | 2528 |
|
|
2019
Q1 | $30M | Sell |
9,910,519
-323,683
| -3% | -$1.05M | ﹤0.01% | 2557 |
|
|
2018
Q4 | $27.8M | Buy |
10,234,202
+304,945
| +3% | +$1M | ﹤0.01% | 2557 |
|
|
2018
Q3 | $33.4M | Buy |
9,929,257
+123,932
| +1% | +$383K | ﹤0.01% | 2594 |
|
|
2018
Q2 | $25.3M | Buy |
9,805,325
+664,681
| +7% | +$1.65M | ﹤0.01% | 2728 |
|
|
2018
Q1 | $20.1M | Sell |
9,140,644
-199,565
| -2% | -$449K | ﹤0.01% | 2774 |
|
|
2017
Q4 | $18.6M | Buy |
9,340,209
+83,916
| +0.9% | +$183K | ﹤0.01% | 2824 |
|
|
2017
Q3 | $30M | Buy |
9,256,293
+77,024
| +0.8% | +$238K | ﹤0.01% | 2584 |
|
|
2017
Q2 | $29.6M | Buy |
9,179,269
+6,286,030
| +217% | +$17.8M | ﹤0.01% | 2559 |
|
|
2017
Q1 | $8.22M | Buy |
+2,893,239
| New | +$6.96M | ﹤0.01% | 3205 |
|
|
2016
Q2 | – | Sell |
-10,894
| Closed | -$10K | – | 3857 |
|
|
2016
Q1 | $10K | Buy |
10,894
+7,609
| +232% | +$7.36K | ﹤0.01% | 3172 |
|
|
2015
Q4 | $4K | Sell |
3,285
-1,766
| -35% | -$2.46K | ﹤0.01% | 3218 |
|
|
2015
Q3 | $9K | Hold |
5,051
| – | – | ﹤0.01% | 2800 |
|
|
2015
Q2 | $11K | Hold |
5,051
| – | – | ﹤0.01% | 2747 |
|
|
2015
Q1 | $14K | Hold |
5,051
| – | – | ﹤0.01% | 2553 |
|
|
2014
Q4 | $13K | Hold |
5,051
| – | – | ﹤0.01% | 2612 |
|
|
2014
Q3 | $9K | Hold |
5,051
| – | – | ﹤0.01% | 2819 |
|
|
2014
Q2 | $14K | Buy |
5,051
+5
| +0.1% | +$15 | ﹤0.01% | 2581 |
|
|
2014
Q1 | $17K | Hold |
5,046
| – | – | ﹤0.01% | 2449 |
|
|
2013
Q4 | $23K | Hold |
5,046
| – | – | ﹤0.01% | 2302 |
|
|
2013
Q3 | $20K | Hold |
5,046
| – | – | ﹤0.01% | 2287 |
|
|
2013
Q2 | $21K | Buy |
+5,046
| New | +$19.5K | ﹤0.01% | 2284 |
|
Other funds holding ATRS
BlackRock's ATRS Position: Q2 2022 in Review
BlackRock sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 11,954,171 shares — an estimated $49M sold.
BlackRock first reported a position in ATRS in Q2 2013 and held it in 33 quarters. The position peaked at $53.9M in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- BlackRock reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- BlackRock sold 11,954,171 Antares Pharma, Inc. shares in Q2 2022, an estimated $49M.
- BlackRock first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 33 quarters.
- BlackRock's Antares Pharma, Inc. position peaked at $53.9M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.